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Summary: A fluorometric assay in microtitre plates for the screening of phenylketonuria was evaluated and adapted
to a neonatal screening programme. Using this assay, it is possible to deterraine quantitatively the phenylalanine
concentration in dried blood Spots on fiiter paper. The test exhibited a linear calibration curve with a good slope äs
well äs sufficient precision and accuracy in the statistical analysis.
Interference by other amino acids and antibiotics was not observed. Only elevated concentrations of leucine inter-
fered to a small degree.
l
! The phenylalanine concentration in dried blood spots of 13 phenylketonuria patients correlated to that in serum.
| 7381 dried blood samples of newborn infants were tested simultaneously by both the fluorometric and the Guthrie
test. The results did not show significant differences.
We screened 29182 newborns using the fluorometric assay and an online data processing programme. The internal
!( repetition rate was 0.64%, the external recall rate 0.15%. False negative results were not observed.
In December 1991 the fluorometric methöd replaced the Guthrie test in our routine programme for phenylketonuria
screening, and was introduced äs a follow up test for phenylketonuria patients.
Introduction Succinic acid (No. S7501); cupric sulphate (No. C7631); sodium
potassium tartrate (No. S2377); sodium carbonate (No. S4132)
Phenylketonuria is a congenital disorder of phenylala- we* frora SiSma Chemicals, 82041 Deisenhofen, Germany.
nine metabolism, which is SUltable for screening. Several Z,-Leucyk£-alanine (No. 61960) was from Fluka Feinchemikalien
assays have been developed for its early detection. A GmbH' 89233 Neu'Ulm' Germany·
fluorometric procedure for measurement of phenylala- Microplates (No. 655101) were frorn Greiner GmbH, 72622
nine in serum published by McCaman & Robins (1) has mßen' ennany·
been adapted by some authors for phenylketonuria !̂ or?^. \ ' . , t , , ,* * ^ (No· L2-410-001) were from Merlin Diagnostika GmbH, 53332
sereerimg m dned blood spots (2, 3, 4). Bomheim-Hersel, Germany.
We adapted the riiethod to our neonatal screening pro-
gramme for estimation of phenylalanine in dried blood Solutions
spots using a micfOpiate (5, 6, 7) and data processing 1. Solution for protein precipitation: methanol/acetone/distilled
SVStem water (3.5 + 3.5 + l, by vol.), stable for 2 weeks at room temper-
ature.
2. Elution of blood spots: distilled water.
mx ^ . , 3. Succinate buffef: succinic acid 0.2 mol/1 distilled waten pH 5.9,Matenals and Methode stable for 2 weeks at 4 °C.
Material 4. Ninhydrin: 27 g/l distilled water, stable for 2 weeks at 4 °C
Acetone (No. 14); methanol (No. 6011); ninhydrin(No. 6762) were 5. L-Leucyl-I-alanine: 5 g/l distilled water, stable for l weeks at
from E. Merck, 64283 Dannstadt, Germany. 4 °C.
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6. Incubation mixture: succinate buffer/ninhydrin/L-leucyl-L-ala-
nine (5 + 3 + l, by vol.), prepared freshly.
7. Copper concentrate: 0.6 g cupric sulphate, 0.83 g sodium potas-
sium tartrate and 17.6 g sodium carbonate dissolved separately in
small amounts of distilled water, mixed in the described order and
adjusted \vith distilled water to 11, stable for 2 weeks at 4 °C.
8. Copper reagent: 2 volumes of distilled water added to l volume
of copper concentrate, prepared freshly.
Calibrators
The heparinized blood of a healthy, fasting volunteer was supple-
mented with different amounts of a stock solution of phenylalanine.
The final concentration was measured in the plasma by high perfor^
mance liquid chromatography. Calibrators were produced äs fol-
lows: 25 of the enriched blood were dropped on filter paper
cards (Schleicher & Schüll, No. 2992, 37586 Dassel, Germany).
We used phenylalanine concentrations of 0.06, 0.19, 0.32 and 0.67
mmol/1 (1.0, 3.2, 5.3, 11.1 mg/dl) äs calibrators for the assay in
duplicate, and two concentrations äs controls placed in the last twp
positions of each fluoroplate.
Neonatal blood samples
Blood of newborns was collected on filter paper cards on the fourth
or fifth postnatal day and mailed to our screening laboratory, where
the test was performed on the day of receipt. The blood samples
were taken from our routine neonatal screening programme.
Procedure
A single disc, 4.3 mm in diameter, was punched out from the filter
paper card of each patient and each calibrator and placed in a well
of a microplate. Fourty of solution for protein precipitation (No.
1) were added to each well and evaporated at 60 °C for 30 min.
The amino acids were eluted in 145 of distilled water per well
for 20 min on a shaker at room temperature. After removing the
discs the plates were shaken again for 10 min. An aliquot (55 )
of eluate from each well was transferred to a fluoroplate and 45
of incubation mixture (No. 6) were added. The covered plates were
incubated for 100 min at 60 °C and shaken during incubation.
Thereafter the plates were cooled for 5 min at -20 °C and 280
of copper reagent (No. 8) were added. The plates were shaken
again for 15 min and the fluorescence units were determined within
45 min.
mg/dl) again, the responsible physician or the parents of the
born infant were informed and a second blood sample was re-
quested.
Results
Linearity of the calibration curve
Linearity was assessed by 20 replicate analyses of 10
calibrators ranging from 0.04 mmol/1 (0.7 mg/dl) to 1.25
mmol/1 (20.7 mg/dl) phenylalanine with a coefficient of
correlätion of r = 0.995 (flg. 1).
Precision
The coefficients of Variation of the within^run precision
determined by 20 replicates of 10 different calibrators
contairiing phenylalanine concentrations between 0.04
mmol/1 (0.7 mg/dl) and 1.25 mmol/1 (20.7 mg/dl) did
not exceed 5% in the ränge above the cut off value of
0.15 mmol/1 (2.5 mg/dl). The coefficients of Variation of
the run-to-run precision were assessed by assaying 10
different calibrators on 20 consecutive days and were
less than 10% with phenylalanine cpncemtrations above
the cut off value (fig. 2).
Accuracy
The fluorometric measurement of the phenylalanine
concentration in dried blood spots of 13 phenylketonuria
patients undergoing dietary treatment was compared
with that in plasma by high perforrnance liquid chroma-
tography of the same blood samples. The patients
showed phenylalanine conceritrations in serum between
0.12 mmol/1 (1.9 mg/dl) and 1.3 mmol/1 (21.4 mg/dl).
The coefficient of correlätion between both procedures
was 0.979.
Measurement
A wavelength of 355 nm for excitation and 460 nm for emission
was used. The fluorometer was controlled by a Computer and ad-
justed automatically. The measured fluorescence units were träns-
ferred to the Computer on-line and calculated in terms of concentra-
tions.
Evaluation
The fluorescence units were displayed on a Computer screen di-
rectly after the measurement. So it was possible to check any high
values. This occurred in about 0.6% of cases, because of small dust
fibres on the surfaces. After removing the fibres, the measurement
was repeated without any disturbances. A data proeessing Pro-
gramme calculated the calibration curve, the coefficient of correlä-
tion (r) and the phenylalanine concentrations of the blood samples.
Samples with phenylalanine concentrations above the cutoff välüe
of 0.15 mmol/1 (2.5 mg/dl) were marked and printed separately.
In cases of elevated results, the arialysis was repeated on the
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Fig. l Linear regression of calibration eurve öf 10 phenylalanine
concentrations, » »
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Fig. 2 Coefficients of Variation of within-run precision (HD—)
and run-to-run precision (—B—) of 10 phenylalanine Standards.
Specifity
The influence of other amino acids was tested in dried
blood spots supplemented with methionine, tyrosine,
histidine, ornithine, proline, glutamine, valine, leucine
and isoleucine up to 1.21 mmol/1 (20 mg/dl) instead of
phenylalanine. The fluorescence of such preparations
did not exceed that corresponding to a phenylalanine
concentration of 0.08 mmol/1 (1.3 mg/dl), except for leu-
cine, which caused significant interference at concentra-
tions above 0.5 mmol/1 (8 mg/dl), corresponding to phe-
nylalanine concentrations up to 0.2 mmol/1 (3.4 mg/dl).
Comparison of the fluorometric and
Guthrie test
Blood samples (n = 7381) were measured üsüag both
the fluorometric and the Guthrie test. In the Guthrie test
320 samples (4.3%) had to be retested after heat treat^
ment becaüse öf antibiotic substances, 51 internal repeti-
tions (0.7%) had tP be rnade düe to questionable results
and 11 second samples (0.15%) were requested becaüse
of elevated phenylalanine levels after repetitipri. The ser
cond blood samples showed normal phenylalanine con-
centrations.
The fluorometric assay caused orily 47 internal repeti-
tions (0.64%), and 11 external recalls (0.15%) were nec-
essary. None of previous elevated phenylalanine levels
could be confirmed in the second sample.
These data reveal that the low number of false positive
results is a great advantage over the Guthrie test. The
fluorometric test also proves to be the more suitable
screening method with respect to overatl processing
time (4.5 h versus 24 h and longer), and material and
reagent costs.
Fluorometric routine screening
Samples (n = 21801) were screened using the fluoro-
metric method. To process 300 blood samples, one labo-
ratory assistant needed about 4.5 hours. With a cutoff
value of 0.15 mmol/1 (2.5 mg/dl) phenylalanine we had
to repeat 124 of the samples (0.57%), mostly due to
unspecific fluorescence caused by dust fibres in the
microwells. In 45 cases (0.21%) the results remained
positive after the repetition test, and a second sample
was requested. Eight of these samples (0.04%) had a
phenylalanine concentration above the cutoff value.
Those babies were introduced to a university clinic for
further diagnosis. Two of them (0.01%) were in need of
treatment for hype henylalaninaemia. We are not aware
of any false negative results.
Figure 3 shows the distribution of the blood phenylala-
nine concentrations of 29182 samples. The mean value
is 0.06 mmol/1 (1.06 mg/dl) phenylalanine, SD = 0.50
mg/dl.
Discussion
The practical experience and the statistical data of this
fluorometric method demonstrate its suitability for neo-
natal phenylketonuria screening. It also showed suffi-
cient accuracy for dietary control of phenylketonuria pa-
tients.
The short time needed for the test allows a second analy-
sis on the following day. Reagent costs are low and there
are only few false positive results. We are not aware of
false negative results. The online data processing re-
duces the sources of errors by laboratory staff.
In comparison with the Guthrie bacterial Inhibition as-
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Fig. 3 Distribution of phenylalanine concentration in dried
blood samples.
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advantages. Therefore the "Staatliches Medizinahuiter-
suchungsamt Hannover" (Public Health Laboratory of
Hannover) replaced the Guthrie test for routine phenyl-
ketonuria screening in December 1991. No important
Problems have since been encountered in the testing of
more than 100000 samples.
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